FRAME: Romosozumab Rapidly Reduces Fracture Risk in Osteoporosis FRAME: Romosozumab Rapidly Reduces Fracture Risk in Osteoporosis

Romosozumab rapidly and dramatically reduces vertebral fractures compared with placebo in FRAME, and bone-enhancing effects continue after patients are transitioned to denosumab for a further year.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news